Burning Rock Biotech (BNR) Receivables - Other (2019 - 2025)
Burning Rock Biotech has reported Receivables - Other over the past 7 years, most recently at $1.7 million for Q4 2025.
- For Q4 2025, Receivables - Other fell 10.08% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $1.7 million, down 10.08%, while the annual FY2025 figure was $1.8 million, 7.32% down from the prior year.
- Receivables - Other for Q4 2025 was $1.7 million at Burning Rock Biotech, down from $1.8 million in the prior quarter.
- Over five years, Receivables - Other peaked at $8.1 million in Q2 2023 and troughed at $1.7 million in Q4 2025.
- A 5-year average of $4.6 million and a median of $4.1 million in 2021 define the central range for Receivables - Other.
- Biggest five-year swings in Receivables - Other: soared 20626.75% in 2021 and later plummeted 68.36% in 2024.
- Year by year, Receivables - Other stood at $6.6 million in 2021, then fell by 11.45% to $5.9 million in 2022, then crashed by 46.19% to $3.2 million in 2023, then tumbled by 38.95% to $1.9 million in 2024, then dropped by 10.08% to $1.7 million in 2025.
- Business Quant data shows Receivables - Other for BNR at $1.7 million in Q4 2025, $1.8 million in Q3 2025, and $2.1 million in Q2 2025.